Recent news on Pantoprazole Sodium

Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning ...  -  Apr 16, 2007
Drug Newswire (press release),Prevacid(R) (lansoprazole), Prilosec(R) (omeprazole), or Protonix(R) (pantoprazole sodium). Viagra(R) (sildenafil citrate), Levitra(R) (vardenafil HCl),

Nycomed officially launched as combined group  -  Jan 16, 2007
CNW Telbec (Communiqués de presse),In 2006 most Nycomed products showed growth, with Pantoloc(R) (pantoprazole sodium), remaining the largest single product by revenue.



Teva gets FDA approval for pantoprazole sodium DR tablets  Apr 23, 2006
...approval for the company's abbreviated new drug application (ANDA) to market its generic version of Wyeth's Protonix (pantoprazole sodium) delayed release (DR ... - Globes

STABILITY OF OMEPRAZOLE SODIUM AND PANTOPRAZOLE SODIUM DILUTED FOR ...  Apr 21, 2006
BACKGROUND: Proton-pump inhibitors are often administered by intravenous infusion to raise intragastric pH and prevent rebleeding following endoscopic ... - The Journal of Pharmacy Technology

Teva Receives Tentative Approval for Generic Protonix(R) Delayed ...  Apr 21, 2006
...approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Wyeth's Protonix(R) (Pantoprazole Sodium) Delayed Release ... - International News Service

Teva Granted Tentative FDA Approval For Generic Protonix Delayed ...  Apr 21, 2006
New Drug Application to market its generic version of Wyeth's Protonix Delayed Release Tablets, 20 mg and 40 mg.Teva's Pantoprazole Sodium DR Tablets will be ... - Trading Markets

Teva OK'd on generic of Wyeth's Protonix  Apr 21, 2006
Food and Drug Administration has given tentative approval to its generic version of Wyeth's Protonix Sodium Delayed Release Tablets (pantoprazole sodium) in 20 ... - United Press International

Teva's generic Protonix gets FDA approval  Apr 21, 2006
Teva's pantoprazole sodium DR (delayed release) tablets are the equivalent of Wyeth's Protonix DR tablets. The brand name had 2005 sales of about $2.4 billion. ... - BusinessWeek

ADR Report: Latin America, Asia Lift Composite Index -2-  Apr 21, 2006
...hypersecretory conditions. Israel's Teva is currently involved in a patent-litigation lawsuit over its pantoprazole sodium tablets. The ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional